Crossmark

Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?

Published Online: 2016-02-29

Published Print: 2016-04

Authors

Kovács, Á.

Alogna, A.

Post, H.

Hamdani, N.
License Information

Text and Data Mining valid from 2016-02-29

Version of Record valid from 2016-02-29
More Information

Article History

Received: 22 October 2015

Accepted: 21 January 2016

First Online: 29 February 2016

Conflict of interests

: None declared.

Document is current